A NEW GENERATION
OF STETHOSCOPE INTELLIGENT AUTONOMOUS EASY TO USE

A medical device which facilitates the diagnosis and follow-up of respiratory diseases

COVID-19

Our studies show that respiratory diseases have their own “acoustic signature” identifiable by artificial intelligence better than by the human ear.
Authorities in 221 countries and territories have reported about 225.5 million Covid‑19 cases and 4.65 million deaths since December 2019. Our AI-driven stethoscope can determine who is affected, predict the outcome of the pulmonary disease in hospitalized patients, alert those confined at home and their doctor by telemedicine when their situation deteriorates. Overall medical management and health costs could be tremendously improved.

Asthma

Asthma affects 350 million people and is the leading chronic disease in children. People with asthma get difficulties to objectively define the severity of symptoms. Fear, anxiety and isolation considerably impair judgement, this is even more exacerbated for a parent who sees his asthmatic child starting an attack.
By using our AI-driven stethoscope, each parent will be able to objectively assess the severity of symptoms, be advised in real time on the treatment and the need of a medical consultation to make the best choice for their child’s health.

Pneumonia

According to the World Health Organization (WHO), 1 million children die every year due to pneumonia. 16% of overall deaths occurs in children under five, 80% within the first two years of life. In low resources settings doctors are scarce and Health Care Workers (HCW) poorly trained to diagnose pneumonia, often leading to patients’ death or to antibiotic overuse.
Our AI-driven stethoscope facilitates HCWs clinical decision-making saving millions of lives every year in cities as in remote areas of low-and-middle income countries.

A simple 3 steps process

Watch our video

What our customer say about us

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis, ultricies nec, pellentesque eu, pretium quis, sem. Nulla consequat massa quis enim.

Markus MeyerCEO – Floorfilla Media

Donec quam felis, ultricies nec, pellentesque eu, pretium quis, sem. Nulla consequat massa quis enim. Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus.

Susan ChariceCTO – Mambajuice

Who are we?
What do we do?

The Pneumoscope project was initiated at the Geneva University Hospitals (HUG) in 2017 by Professor Alain Gervaix.
The objectives were to standardise lung auscultation to help healthcare professionals to better diagnose pulmonary diseases. More than 160’000 respiratory cycles of healthy and sick patients suffering from bronchiolitis, asthma, pneumonia, Covid-19, COPD, tuberculosis, etc. have been recorded by 35 collaborators in 10 countries.
In collaboration with the Swiss Institute of Technology in Lausanne (EPFL) and the Engineer School of Geneva (HEPIA), a team of scientists and doctors came together to develop their own digital stethoscope, pulse oximeter and thermometer in a single 3-in-1 AI-driven medical device.

The current COVID-19 pandemic taught us how our device can be used for population mass screening by non-medical staff and also by any citizen for self-testing when confined home.

1500000

CHF raised

160000

respiratory cycles recorded

collaborators involved

on going clinical studies